{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:30:01Z","timestamp":1786627801611,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00228-021-03186-x","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:03:07Z","timestamp":1626426187000},"page":"1927-1933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project"],"prefix":"10.1007","volume":"77","author":[{"given":"Lamuela L. J.","family":"Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Llorente Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sierra Gabarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Monz\u00f3n Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Arbon\u00e9s Mainar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Alcedo Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-2165","authenticated-orcid":false,"given":"V.","family":"Bernal Monterde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"issue":"4","key":"3186_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX (2017) The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 152(4):706\u2013715","journal-title":"Gastroenterology"},{"key":"3186_CR2","unstructured":"Subgrupos ATC (2017) y principios activos de mayor consumo en el Sistema Nacional de Salud en 2017. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2017. Informe Anual de gasto farmac\u00e9utico del Sistema Nacional de Salud 2018; Available from: https:\/\/www.mscbs.gob.es\/estadEstudios\/estadisticas\/sisInfSanSNS\/tablasEstadisticas\/InfAnualSNS2018\/Cap.7_Farmacia.pdf"},{"issue":"11","key":"3186_CR3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14740338.2019.1664470","volume":"18","author":"A Lanas-Gimeno","year":"2019","unstructured":"Lanas-Gimeno A, Hijos G, Lanas \u00c1 (2019) Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opin Drug Saf 18(11):1043\u20131053","journal-title":"Expert Opin Drug Saf"},{"key":"3186_CR4","doi-asserted-by":"crossref","unstructured":"de-la-Coba C, Arg\u00fcelles-Arias F, Mart\u00edn-de-Argila C et al (2016)\u00a0Efectos adversos de los inhibidores de la bomba de protones: revisi\u00f3n de evidencias y posicionamiento de la Sociedad Espa\u00f1ola de Patolog\u00eda Digestiva. Rev Espa\u00f1ola Enfermedades Dig. 108(4):207\u201324","DOI":"10.17235\/reed.2016.4232\/2016"},{"issue":"12","key":"3186_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","volume":"14","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Kandulski A, Venerito M (2017) Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol 14(12):697\u2013710","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"3186_CR6","first-page":"291","volume":"71","author":"PJ Zed","year":"2018","unstructured":"Zed PJ (2018) Deprescribing proton pump inhibitors. Can J Hosp Pharm 71(5):291","journal-title":"Can J Hosp Pharm"},{"issue":"5","key":"3186_CR7","first-page":"354","volume":"63","author":"B Farrell","year":"2017","unstructured":"Farrell B, Pottie K, Thompson W et al (2017) Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician 63(5):354\u2013364","journal-title":"Can Fam Physician"},{"issue":"10","key":"3186_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/mja18.00674","volume":"209","author":"P Bytzer","year":"2018","unstructured":"Bytzer P (2018) Deprescribing proton pump inhibitors: why, when and how. Med J Aust 209(10):436\u2013438","journal-title":"Med J Aust"},{"key":"3186_CR9","doi-asserted-by":"crossref","unstructured":"Boghossian TA, Rashid FJ, Thompson W et al (2017)\u00a0Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. (3)","DOI":"10.1002\/14651858.CD011969.pub2"},{"issue":"7","key":"3186_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1365-2036.2009.04092.x","volume":"30","author":"C Reimer","year":"2009","unstructured":"Reimer C, Bytzer P (2009) Clinical trial: long-term use of proton pump inhibitors in primary care patients\u2013a cross sectional analysis of 901 patients. Aliment Pharmacol Ther 30(7):725\u2013732","journal-title":"Aliment Pharmacol Ther"},{"issue":"975","key":"3186_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/pgmj.2006.051151","volume":"83","author":"BT Batuwitage","year":"2007","unstructured":"Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL (2007) Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 83(975):66\u201368","journal-title":"Postgrad Med J"},{"issue":"9","key":"3186_CR12","first-page":"e228","volume":"16","author":"JJ Heidelbaugh","year":"2010","unstructured":"Heidelbaugh JJ, Goldberg KL, Inadomi JM (2010) Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 16(9):e228\u2013e234","journal-title":"Am J Manag Care"},{"issue":"11","key":"3186_CR13","first-page":"3118","volume":"95","author":"RJ Nardino","year":"2000","unstructured":"Nardino RJ, Vender RJ, Herbert PN (2000) Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 95(11):3118\u20133122","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"3186_CR14","first-page":"652","volume":"107","author":"E Villama\u00f1\u00e1n","year":"2015","unstructured":"Villama\u00f1\u00e1n E, Ruano M, Lara C et al (2015) Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care. Rev Espa\u00f1ola Enfermedades Dig 107(11):652\u2013658","journal-title":"Rev Espa\u00f1ola Enfermedades Dig"},{"issue":"10","key":"3186_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","volume":"21","author":"DA Zink","year":"2005","unstructured":"Zink DA, Pohlman M, Barnes M, Cannon ME (2005) Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther 21(10):1203\u20131209","journal-title":"Aliment Pharmacol Ther"},{"key":"3186_CR16","unstructured":"National Institute for Health and Care Excellence (NICE) (2014)\u00a0Gastrooesophageal reflux disease and dyspepsia in adults: investigation and management [updated 2014; cited Nov 2016]. Clin Guidel [CG184]"},{"key":"3186_CR17","doi-asserted-by":"crossref","unstructured":"Par\u00e9 P, Meyer F, Armstrong D et al (2003)Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol. 17","DOI":"10.1155\/2003\/530984"},{"issue":"1","key":"3186_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gastrohep.2008.09.006","volume":"32","author":"DMA Ruiz","year":"2009","unstructured":"Ruiz DMA, Su\u00e1rez PJM, Pardo MA et al (2009) Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire. Gastroenterol Hepatol 32(1):9","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"3186_CR19","first-page":"32","volume":"100","author":"AD Halli-Tierney","year":"2019","unstructured":"Halli-Tierney AD, Scarbrough C, Carroll D (2019) Polypharmacy: evaluating risks and deprescribing. Am Fam Physician 100(1):32\u201338","journal-title":"Am Fam Physician"},{"key":"3186_CR20","doi-asserted-by":"publisher","unstructured":"Bonini G, Pasina L, Cortesi L et al (2020) Inappropriate prescribing in intermediate care facilities. Aging Clin Exp Res. 2020 May 28. doi: https:\/\/doi.org\/10.1007\/s40520-020-01602-3. Epub ahead of print. PMID: 32468506","DOI":"10.1007\/s40520-020-01602-3"},{"issue":"2","key":"3186_CR21","first-page":"76","volume":"100","author":"E Mart\u00edn-Echevarr\u00eda","year":"2008","unstructured":"Mart\u00edn-Echevarr\u00eda E, Pereira Juli\u00e1 A, Torralba M et al (2008) Evaluaci\u00f3n del uso de los inhibidores de la bomba de protones en un servicio de medicina interna. Rev Espa\u00f1ola Enfermedades Dig 100(2):76\u201381","journal-title":"Rev Espa\u00f1ola Enfermedades Dig"},{"key":"3186_CR22","first-page":"2227","volume":"2015","author":"BCU Expert","year":"2015","unstructured":"Beers Criteria Update Expert panel A (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015:2227\u20132246","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"3186_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","volume":"24","author":"E Bj\u00f6rnsson","year":"2006","unstructured":"Bj\u00f6rnsson E, Abrahamsson H, Simren M et al (2006) Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 24(6):945\u2013954","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3186_CR24","first-page":"141","volume":"20","author":"J Murie","year":"2012","unstructured":"Murie J, Allen J, Simmonds R, de Wet C (2012) Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice. Qual Prim Care 20(2):141\u2013148","journal-title":"Qual Prim Care"},{"issue":"10","key":"3186_CR25","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/MEG.0b013e32833d56d1","volume":"22","author":"C Reimer","year":"2010","unstructured":"Reimer C, Bytzer P (2010) Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. Eur J Gastroenterol Hepatol 22(10):1182\u20131188","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3186_CR26","doi-asserted-by":"crossref","unstructured":"Zwisler JE, Jarb\u00f8l DE, Lassen AT et al (2015)\u00a0Placebo-controlled discontinuation of long-term acid-suppressant therapy: a Na trial in general practice. Int J Family Med. 2015","DOI":"10.1155\/2015\/175436"},{"issue":"2","key":"3186_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1071\/HC15946","volume":"8","author":"K Walsh","year":"2016","unstructured":"Walsh K, Kwan D, Marr P et al (2016) Deprescribing in a family health team: a study of chronic proton pump inhibitor use. J Prim Health Care 8(2):164\u2013171","journal-title":"J Prim Health Care"},{"issue":"3","key":"3186_CR28","first-page":"215","volume":"70","author":"C Lee","year":"2017","unstructured":"Lee C, Lo A, Ubhi K, Milewski M (2017) Outcome after discontinuation of proton pump inhibitors at a residential care site: quality improvement project. Can J Hosp Pharm 70(3):215","journal-title":"Can J Hosp Pharm"},{"issue":"21","key":"3186_CR29","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.3390\/ijms20215469","volume":"20","author":"H Helgadottir","year":"2019","unstructured":"Helgadottir H, Bjornsson ES (2019) Problems associated with deprescribing of proton pump inhibitors. Int J Mol Sci 20(21):5469","journal-title":"Int J Mol Sci"},{"key":"3186_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/fampra\/cmu050","volume":"31","author":"P Haastrup","year":"2014","unstructured":"Haastrup P, Paulsen MS, Begtrup LM et al (2014) Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract 31:625\u2013630","journal-title":"Fam Pract"},{"issue":"9","key":"3186_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/2042098618784809","volume":"9","author":"IA Scott","year":"2018","unstructured":"Scott IA, Pillans PI, Barras M, Morris C (2018) Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Ther Adv drug Saf 9(9):559\u2013573","journal-title":"Ther Adv drug Saf"},{"issue":"1","key":"3186_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jcpt.12613","volume":"43","author":"M Naunton","year":"2018","unstructured":"Naunton M, Peterson GM, Deeks LS et al (2018) We have had a gutful: the need for deprescribing proton pump inhibitors. J Clin Pharm Ther 43(1):65\u201372","journal-title":"J Clin Pharm Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03186-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03186-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03186-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T06:04:13Z","timestamp":1636610653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03186-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3186"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03186-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research complied with the guidelines for human studies and was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. Subjects have given their written informed consent. This study was approved by our Institutional Review Board (Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica de Arag\u00f3n, CEIC-A, reference number: EPA20\/023, on April 29, 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}